Transparency Market Research Reports included a detailed market survey and analysis trends on “”. This report also includes more info about basic overview of the industry including definitions, applications and global market industry structure.Sleep disorder is a deviation in the normal sleeping
pattern. It can also be defined as difficulty related to sleeping that
includes falling asleep at inappropriate time, excessive sleep and
abnormal behavior associated with the sleep. Sleep disorders are
classified into four categories namely, dyssomnias, parasomnias,
proposed sleep disorder and medical disorder.
Browse Full Report with TOC:
Dyssomnia is the
disturbance in quality, time and amount of sleep. It is further
classified as intrinsic sleep disorder, circadian rhythm sleep disorder
and extrinsic sleep disorder. Circadian Rhythm Sleep Disorders (CRSD)
are a family of disorders that affects the sleep of an individual.
- Delayed Sleep Phase Disorder (DSP)
- Jet Lag Disorder
- Irregular Sleep-Wake Rhythm
- Free-Running (nonentrained) type
- Shift Work Disorder
- Advanced Sleep Phase Disorder (ASP)
Increasing
geriatric population coupled with rising prevalence of chronic
disorders are some of the major factors driving the growth of CRSD
market globally. The global population is aging, especially in developed
countries that includes the U.S., Europe and Japan. It has been
estimated that the global geriatric population would rise from 760
million (11%) in 2011 to 2 billion (2050). Thus, increasing geriatric
population accentuates the growth of this market. However, lack of
awareness among the patient population is one of the restraining factors
for this market.
Geographically,
North America and Europe accounted for the largest share of the global
CRSD market owing to increasing geriatric population and rising
prevalence of chronic diseases. According to Eurostat (European
Commission) report in 2013, around 17.8% of the European population was
above the age of 65 years. Thus, this increase in geriatric population
propels the growth of CRSD in European region.
Vanda
Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, VU
University Medical Center, U.S. Centers of Disease Control and
Prevention are some of the manufacturers and research organizations
engaged in developing therapeutics for the development of CRSD market.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
Transparency
Market Research (TMR) is a market intelligence company providing global
business research reports and consulting services. Our exclusive blend
of quantitative forecasting and trends analysis provides forward-looking
insights for thousands of decision-makers.
No comments:
Post a Comment